Sudeep Pharma Ltd Board Meeting Scheduled for May 21, Reviewing Q4 Results and Dividend
Sudeep Pharma Ltd has announced that its Board of Directors meeting is scheduled for Thursday, May 21, 2026.The meeting is set to address key corporate decisions, including the approval of the Audited Standalone and Consolidated Financial Results for the fourth quarter and the fiscal year ended on March 31, 2026. Additionally, the board will consider making a recommendation for a Final Dividend, if deemed necessary, on the company's Equity Shares for the Financial Year 2025-26.
The company also provided details regarding the closure period for the Trading Window for persons covered under the Code of Internal Procedure and Conduct of Regulating, Monitoring and Reporting of Trading in Securities by Insiders. The Trading Window was closed from Wednesday, April 1, 2026, through Saturday, May 23, 2026.
The mandated closure period for the Trading Window is detailed as follows:
| Event | Start Date | End Date |
|---|---|---|
| Trading Window Closure | Wednesday, April 1, 2026 | Saturday, May 23, 2026 |
This period covers both days inclusive.
SUDEEPPHRM Stock Price Movement
Sudeep Pharma Limited shares are edging higher to ₹640.3 as of 10:24 AM today, gaining 0.94% in live trading. The stock has seen active buying throughout the session, remaining within the intraday range of ₹634.95 to ₹647.95 on a volume of 7,636 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.